nu-7441 has been researched along with quizartinib* in 1 studies
1 other study(ies) available for nu-7441 and quizartinib
Article | Year |
---|---|
Quantitative phosphoproteomics uncovers synergy between DNA-PK and FLT3 inhibitors in acute myeloid leukaemia.
Topics: Benzothiazoles; Chromones; DNA-Activated Protein Kinase; Drug Synergism; Drug Therapy, Combination; fms-Like Tyrosine Kinase 3; Humans; Leukemia, Myeloid, Acute; Morpholines; Phenylurea Compounds; Phosphoproteins; Proteome; Tumor Cells, Cultured | 2021 |